Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals
Alison Tarke, John Sidney, Nils Methot, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 7, pp. 100355-100355
Open Access | Times Cited: 618

Showing 1-25 of 618 citing articles:

The T cell immune response against SARS-CoV-2
Paul Moss
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 186-193
Open Access | Times Cited: 1085
The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 976
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
Rishi R. Goel, Mark M. Painter, Sokratis A. Apostolidis, et al.
Science (2021) Vol. 374, Iss. 6572
Open Access | Times Cited: 782
SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron
Alison Tarke, Camila H. Coelho, Zeli Zhang, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 847-859.e11
Open Access | Times Cited: 760
Antibody evasion by the P.1 strain of SARS-CoV-2
Wanwisa Dejnirattisai, Daming Zhou, Piyada Supasa, et al.
Cell (2021) Vol. 184, Iss. 11, pp. 2939-2954.e9
Open Access | Times Cited: 616
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
Roanne Keeton, Marius B. Tincho, Amkele Ngomti, et al.
Nature (2022) Vol. 603, Iss. 7901, pp. 488-492
Open Access | Times Cited: 536
SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients
Daryl Geers, Marc C. Shamier, Susanne Bogers, et al.
Science Immunology (2021) Vol. 6, Iss. 59
Open Access | Times Cited: 520
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
Sokratis A. Apostolidis, Mihir Kakara, Mark M. Painter, et al.
Nature Medicine (2021) Vol. 27, Iss. 11, pp. 1990-2001
Open Access | Times Cited: 472
Humoral and cellular immune memory to four COVID-19 vaccines
Zeli Zhang, José Mateus, Camila H. Coelho, et al.
Cell (2022) Vol. 185, Iss. 14, pp. 2434-2451.e17
Open Access | Times Cited: 444
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
Alasdair Munro, Leila Janani, Victoria Cornelius, et al.
The Lancet (2021) Vol. 398, Iss. 10318, pp. 2258-2276
Open Access | Times Cited: 429
Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination
Mark M. Painter, Divij Mathew, Rishi R. Goel, et al.
Immunity (2021) Vol. 54, Iss. 9, pp. 2133-2142.e3
Open Access | Times Cited: 426
Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients
Corine H. GeurtsvanKessel, Daryl Geers, Katharina S. Schmitz, et al.
Science Immunology (2022) Vol. 7, Iss. 69
Open Access | Times Cited: 404
Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant
Yu Gao, Curtis Cai, Alba Grifoni, et al.
Nature Medicine (2022) Vol. 28, Iss. 3, pp. 472-476
Open Access | Times Cited: 400
Novel SARS-CoV-2 variants: the pandemics within the pandemic
Erik Boehm, Ilona Kronig, Richard A. Neher, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 8, pp. 1109-1117
Open Access | Times Cited: 358
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
Sandile Cele, Laurelle Jackson, David S. Khoury, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 342
The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic
Sarah P. Otto, Troy Day, Julien Arino, et al.
Current Biology (2021) Vol. 31, Iss. 14, pp. R918-R929
Open Access | Times Cited: 323
Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine
Chunfeng Li, Audrey Lee, Lilit Grigoryan, et al.
Nature Immunology (2022) Vol. 23, Iss. 4, pp. 543-555
Open Access | Times Cited: 312
SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19
Alba Grifoni, John Sidney, Randi Vita, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1076-1092
Open Access | Times Cited: 291
Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease
David Goldblatt, Galit Alter, Shane Crotty, et al.
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 6-26
Open Access | Times Cited: 233
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity
Carolina Lucas, Chantal B. F. Vogels, İnci Yıldırım, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 523-529
Open Access | Times Cited: 226
Immunological memory to SARS‐CoV ‐2 infection and COVID ‐19 vaccines
Alessandro Sette, Shane Crotty
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 27-46
Open Access | Times Cited: 214
The germinal centre B cell response to SARS-CoV-2
Brian J. Laidlaw, Ali H. Ellebedy
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 7-18
Open Access | Times Cited: 213
BNT162b2 vaccination induces durable SARS-CoV-2–specific T cells with a stem cell memory phenotype
Gisella Guerrera, Mario Picozza, Silvia D’Orso, et al.
Science Immunology (2021) Vol. 6, Iss. 66
Open Access | Times Cited: 200
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
Ivana Lazarević, Vera Pravica, Danijela Miljanovic, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1192-1192
Open Access | Times Cited: 183
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
Annika Fendler, Elisabeth G.E. de Vries, Corine H. GeurtsvanKessel, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 385-401
Open Access | Times Cited: 178
Page 1 - Next Page

Scroll to top